Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

by Schmidt, Thomas Andersen , Semb, Anne Grete , Agewall, Stefan , Tamargo, Juan , Savarese, Gianluigi , Rosano, Giuseppe M C , Widimsky, Petr , Wassmann, Sven , Torp-Pedersen, Christian , Borghi, Claudio , Atar, Dan , Gremmel, Thomas , Lewis, Basil S , Sulzgruber, Patrick , Niessner, Alexander , Doehner, Wolfram , Kaski, Juan Carlos , Kjeldsen, Keld , Drexel, Heinz

in Administration, Oral / Anticoagulants - administration & dosage / Anticoagulants - adverse effects / Atrial Fibrillation - diagnosis / Atrial Fibrillation - drug therapy / Atrial Fibrillation - epidemiology / Cardiac arrhythmia / Cardiology / Clinical Decision-Making / Consensus / Decision Support Techniques / Drug therapy / Hemorrhage - chemically induced / Humans / Pharmacology / Risk Assessment / Risk Factors / Stroke / Stroke - diagnosis / Stroke - epidemiology / Stroke - prevention & control / Thromboembolism / Treatment Outcome / Working groups

2019

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

2019

Confirm

Do you wish to request the book?

2019

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

Schmidt, Thomas Andersen,

Semb, Anne Grete,

Agewall, Stefan,

Tamargo, Juan,

Savarese, Gianluigi,

Rosano, Giuseppe M C,

Widimsky, Petr,

Wassmann, Sven,

Torp-Pedersen, Christian,

Borghi, Claudio,

Atar, Dan,

Gremmel, Thomas,

Lewis, Basil S,

Sulzgruber, Patrick,

Niessner, Alexander,

Doehner, Wolfram,

Kaski, Juan Carlos,

Kjeldsen, Keld,

Drexel, Heinz

2019

Overview

Abstract Oral anticoagulation in patients presenting with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 (CHA2DS2-VASc of 2 in women) remains a challenging approach in clinical practice. Therapeutic decisions need to balance the individual benefit of reducing thromboembolic risk against the potential harm due to an increase in bleeding risk in this intermediate risk patient population. Within the current opinion statement of the European Society of Cardiology working group of cardiovascular pharmacotherapy and the European Society of Cardiology council on stroke the currently available evidence on the anti-thrombotic management in patients presenting with a CHA2DS2-VASc of 1 is summarized. Easily applicable tools for a personalized refinement of the individual thromboembolic risk in patients with atrial fibrillation and a CHA2DS2-VASc score of 1 that guide clinicians through the question whether to anticoagulate or not are provided.

Share this book

Add to My Shelf

Publisher

Oxford University Press

Subject

Administration, Oral

/ Anticoagulants - administration & dosage

/ Anticoagulants - adverse effects

/ Atrial Fibrillation - diagnosis

/ Atrial Fibrillation - drug therapy

/ Atrial Fibrillation - epidemiology

/ Cardiac arrhythmia